Smallpox Vaccine Scar

**Understanding the Causes of a Smallpox Vaccine Scar and Why You Might Have One**

What is a smallpox vaccine scar?

A smallpox vaccine scar is a distinctive mark left on the skin after receiving the smallpox vaccine, typically on the upper arm. The scar is the result of the body's reaction to the vaccine, which historically used a live virus related to smallpox called vaccinia virus.

How It Forms:

1. Vaccination Process: 

The vaccine was administered using a technique called multiple puncture or scarification. A bifurcated needle was used to prick the skin multiple times, introducing the vaccine into the dermis.

2. Reaction:

 Within a few days, a red, itchy bump would form at the vaccination site. This bump evolved into a blister, then a pustule, which eventually scabbed over and fell off.

3. Scar Formation:

 The healing process often left a round or oval scar as the tissue repaired itself.

Appearance:

● The scar is typically small (4-8 mm in diameter) and slightly depressed.

● It often has a textured or puckered surface.

● The size and appearance of the scar can vary depending on individual healing and the vaccination method.

Why It's Significant:

The smallpox vaccine was the first successful vaccine ever developed and played a key role in the global eradication of smallpox in 1980. Routine smallpox vaccination stopped in many countries in the 1970s, so having a smallpox vaccine scar is rare in younger generations today.

ACAM2000™

ACAM2000™ is a live, attenuated vaccine used to protect against smallpox. It is based on the vaccinia virus, which is closely related to the variola virus (the virus that causes smallpox) but does not cause the disease itself. The vaccine helps the body develop immunity to smallpox.

Key Features of ACAM2000™:

1. Live Virus: 

The vaccine contains a replication-competent vaccinia virus. This means the virus can replicate in the body after administration, triggering an immune response.

2. Administration Method:

■  It is delivered using a bifurcated needle (a forked needle).

■ A small amount of vaccine is pricked into the skin (scarification technique).

■ This creates a localized infection, leading to a pustule at the injection site and eventually forming a scar.

3. Effectiveness:

■ Provides strong protection against smallpox.

■ It is used primarily for military personnel, laboratory workers, and others who might be at risk of exposure to orthopoxviruses, including bioterrorism scenarios.

4. Scar Formation:

■ Like older smallpox vaccines, ACAM2000™ typically leaves a scar at the vaccination site as a sign of successful vaccination.

Risks and Side Effects:

■ Because it uses a live virus, ACAM2000™ can cause more side effects than modern vaccines, including:

     ▪︎ Fever, fatigue, and rash.

     ▪︎ Rarely, serious complications such as myocarditis (inflammation of the heart muscle) or encephalitis (brain inflammation).

■ Individuals with weakened immune systems, eczema, or certain other health conditions should not receive ACAM2000™.

Current Use:

ACAM2000™ is part of the U.S. Strategic National Stockpile for emergency use in the event of a smallpox outbreak. It is not given routinely, as smallpox has been eradicated globally since 1980.

Dryvax®

Dryvax® was a smallpox vaccine made from a live, attenuated vaccinia virus. It was widely used during the 20th century to protect against smallpox and played a significant role in the eradication of the disease.

Key Features of Dryvax®:

1. Composition:

● It was derived from lyophilized (freeze-dried) vaccinia virus.

● It was made from vaccinia virus grown on the skin of calves and purified for human use.

2. Administration:

● Administered with a bifurcated needle using the scarification method.

● The vaccine caused a localized reaction, forming a pustule and eventually leaving a characteristic scar.

3. Efficacy:

● Highly effective at preventing smallpox when administered before exposure.

● Could also provide some protection if given shortly after exposure to the smallpox virus.

Replacement:

Dryvax® was discontinued in 2008 due to advancements in vaccine technology. It was replaced by ACAM2000™, which uses a modern production method and is safer for large-scale manufacturing.

Side Effects and Risks:

Like ACAM2000™, Dryvax® carried risks due to its live virus content. These included:

● Local reactions such as redness, swelling, and tenderness at the injection site.

● Rare but serious complications, such as:

     ▪︎ Myocarditis (inflammation of the heart muscle).

     ▪︎ Eczema vaccinatum (a severe reaction in individuals with eczema).

     ▪︎ Progressive vaccinia (a serious condition in immunocompromised individuals).

Historical Significance:

● Dryvax® was essential in the successful World Health Organization (WHO) campaigns to eradicate smallpox, culminating in the declaration of smallpox eradication in 1980.

● It was part of the Strategic National Stockpile for potential bioterrorism threats until it was replaced by newer vaccines like ACAM2000™.

Why does the smallpox vaccine leave a scar?

The smallpox vaccine leaves a scar because of the unique method of administration and the body's immune response to the live vaccinia virus in the vaccine. Here's why the scar forms:

1. Administration Method (Scarification):

■ The vaccine is delivered using a bifurcated (two-pronged) needle that punctures the skin multiple times.

■ This creates a small, controlled area of superficial skin damage, introducing the live vaccinia virus into the dermis.

2. Local Reaction:

■ The vaccinia virus replicates at the injection site, triggering an immune response.

■ A red, raised bump forms within a few days, followed by a blister or pustule.

■ Over time, this pustule scabs over and eventually falls off.

3. Healing Process:

■ The body's natural wound-healing process leaves behind a scar.

■ The extent of scarring depends on individual healing factors, like skin type and immune response.

4. Purposeful Reaction:

■ The visible pustule and subsequent scar were considered evidence of a successful vaccination. If no reaction occurred, the vaccination was sometimes repeated to ensure immunity.

Unique Characteristics:

■ The scar is typically small, round, and slightly depressed, with a puckered or textured appearance.

■ It remains permanent because the dermis (the deeper layer of skin) is involved in the vaccination process, and damage to this layer tends to result in scarring.

Comparison with Modern Vaccines:

Most modern vaccines are administered via intramuscular or subcutaneous injections, which do not involve the same level of localized skin damage. As a result, they do not typically leave scars. The smallpox vaccine's method of scarification is a unique exception.



M

Why don’t I have a smallpox vaccine scar?

There are several reasons why you may not have a smallpox vaccine scar:

1. Age and Vaccination History:

● Routine smallpox vaccination ended in most countries by the late 1970s or early 1980s after the global eradication of smallpox was declared in 1980.

● If you were born after this period, you likely never received the smallpox vaccine.

2. Vaccination Technique:

● The smallpox vaccine was administered using a bifurcated needle that caused a characteristic skin reaction and scar.

● If the vaccine wasn't given correctly or didn't "take" (i.e., your body didn't mount the expected reaction), it may not have left a scar.

3. Skin Healing and Individual Variations:

● Some people’s skin heals differently, and the scar may be minimal or unnoticeable

.
● Genetics and individual immune responses can influence how visible the scar becomes.

4. Location of Vaccination:

● The smallpox vaccine was often given on the upper arm, but the scar could be faint or hidden depending on your skin tone, location, or age.

5. Lack of Need for Vaccination:

● Smallpox vaccination was phased out in many countries because the disease was eradicated.

● Unless you belonged to a group at risk (e.g., military personnel, lab workers handling orthopoxviruses), you may never have received the vaccine.

If you're unsure whether you were vaccinated, you can check with a healthcare provider or review your vaccination records.

Does the mpox vaccine cause a scar?

The mpox (monkeypox) vaccine typically does not cause a scar, unlike the smallpox vaccine. Here’s why:

1. Types of Mpox Vaccines:

■ The primary vaccines used for mpox are JYNNEOS™ (Imvamune/Imvanex) and ACAM2000™.

● JYNNEOS™:

     • This is a non-replicating live virus vaccine administered via subcutaneous injection (under the skin).

     • It does not cause the localized skin reaction (pustule) or scarring seen with older smallpox vaccines.

● ACAM2000™:

     • This is a live, replicating vaccinia virus vaccine, administered via scarification (bifurcated needle) like the smallpox vaccine.

     • It can cause a scar, as it induces a localized lesion similar to the smallpox vaccine.

2. Administration Method Matters:

● JYNNEOS™, the more commonly used vaccine for mpox in recent outbreaks, is designed for a modern injection technique that avoids skin scarring.

● ACAM2000™, while effective against mpox, is typically reserved for high-risk groups (e.g., military personnel or lab workers) and may leave a scar due to its administration method.

3. Current Usage:

● JYNNEOS™ is preferred for mpox vaccination in most populations because it is safer, has fewer side effects, and does not result in scarring.

Summary:

If you received JYNNEOS™, you should not have a scar.
If you received ACAM2000™, you might have a scar similar to the smallpox vaccine scar.

Intradermal vaccination

Intradermal vaccination is a method of administering a vaccine directly into the dermis, the layer of skin just below the epidermis. This technique is different from subcutaneous (under the skin) or intramuscular (into the muscle) injections and has specific applications in modern immunization.

How It Works:

■ A small volume of the vaccine (typically 0.1 mL) is injected into the dermis using a special needle or syringe.

■ The dermis contains many immune cells, such as dendritic cells, which can rapidly process the vaccine and stimulate an immune response.

Advantages:

1. Efficient Immune Response:

■ The rich network of immune cells in the dermis makes intradermal vaccination highly effective, even with smaller doses.

2. Dose-Sparing:

■ This method allows lower vaccine doses to achieve similar efficacy, making it useful during vaccine shortages.

3. Targeted Use:

■ Commonly used for certain vaccines, such as rabies, tuberculosis (Mantoux test), and some newer vaccines like JYNNEOS™ (for mpox).

Common Vaccines Given Intradermally:

1. JYNNEOS™ (Mpox Vaccine):

■ In emergencies, it can be administered intradermally as a dose-sparing strategy.

2. Tuberculosis (TB) Test:

■ The Mantoux test for detecting TB exposure involves intradermal injection of tuberculin.

3. Rabies Vaccine:

■ Intradermal administration is used in some regions as a cost-saving strategy.

Technique:

■ A shallow injection is made at an angle (usually 5–15 degrees) to ensure the vaccine is deposited into the dermis.

■ A small, raised blister or wheal (a sign of correct placement) forms at the injection site.

Challenges:

■ Skill Requirement: Proper intradermal injection requires training to ensure the vaccine is administered correctly.

■ Local Reactions: There may be redness, swelling, or itching at the injection site, but these are generally mild.

In summary, intradermal vaccination is a targeted, dose-efficient approach that is particularly useful in resource-limited settings or during vaccine shortages.

Subcutaneous vaccination

Subcutaneous (SC) vaccination is a method of administering a vaccine into the fatty tissue layer just beneath the skin, between the dermis and the muscle. This technique is commonly used for certain types of vaccines and medications.

How It Works:

● A small needle is inserted at a 45-degree angle to deliver the vaccine into the subcutaneous tissue.

● The fat layer has fewer blood vessels than muscle, so the vaccine is absorbed more slowly, which is appropriate for certain types of vaccines.

Common Vaccines Given Subcutaneously:

1. Measles, Mumps, and Rubella (MMR) vaccine.

2. Varicella (chickenpox) vaccine.

3. Yellow fever vaccine.

4. Some doses of rabies vaccine, depending on the protocol.

Injection Sites:

● Commonly used sites for subcutaneous injections include:

1. Upper outer arm (deltoid area).

2. Thigh (for infants and young children).

3. Abdomen, occasionally for other medications or vaccines.

Advantages:

1. Less Pain: 

SC injections are less painful than intramuscular (IM) injections because they avoid deeper muscle tissue.

2. Ease of Administration: 

This method is simpler and can be performed with minimal equipment.

Disadvantages:

1. Slower Absorption: 

The vaccine or medication may take longer to be absorbed compared to IM injections.

2. Limited Volume: 

Subcutaneous tissue cannot accommodate large volumes; typical doses are 0.5–1 mL.

Comparison with Other Methods:

Method	Injection Site	Absorption Speed	Common Vaccines
Subcutaneous (SC)	Fatty tissue under skin	Moderate	MMR, Varicella
Intramuscular (IM)	Muscle (e.g., deltoid)	Faster	Influenza, Hepatitis B
Intradermal (ID)	Dermis (just under skin)	Slow	Tuberculosis, JYNNEOS™

Subcutaneous vaccination is a reliable and widely used method for vaccines that do not require rapid absorption into the bloodstream.

Does a smallpox vaccine scar mean you have immunity against mpox?

A smallpox vaccine scar may indicate some level of cross-protection against mpox (monkeypox), but it does not guarantee full immunity. Here's why:

1. Cross-Protection Between Smallpox and Mpox:

■ Both smallpox and mpox are caused by viruses in the orthopoxvirus family.

■ The smallpox vaccine, which uses the vaccinia virus, provides immunity against smallpox and some protection against other orthopoxviruses, including mpox.

2. Duration of Immunity:

■ Immunity from the smallpox vaccine can last decades, but its effectiveness diminishes over time.

■ Studies suggest that individuals vaccinated against smallpox may have a reduced risk of severe mpox infection, but the level of protection depends on when they were vaccinated.

3. Vaccination Discontinued:

■ Routine smallpox vaccination ended in most countries in the 1970s-1980s, meaning people vaccinated before then may still retain some immunity, but it may not be strong enough to fully protect against mpox.

4. Mpox-Specific Vaccines:

■ For those at risk of mpox, newer vaccines like JYNNEOS™ are specifically designed to protect against both mpox and smallpox.

■ JYNNEOS™ is recommended even for people with a smallpox vaccine scar, as it boosts immunity and offers more reliable protection against mpox.

5. What the Scar Signifies:

■ A smallpox vaccine scar shows successful vaccination and likely immunity to smallpox.

■ It suggests some residual immunity against mpox but does not mean you are fully immune, especially decades after vaccination.

If you are concerned about mpox exposure, getting vaccinated with JYNNEOS™ or ACAM2000™ (depending on availability and suitability) is recommended, even if you have a smallpox vaccine scar.